Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
10.51
+0.29 (2.84%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Atara Biotherapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Atara Biotherapeutics stock have an average target of 13.67, with a low estimate of 10 and a high estimate of 18. The average target predicts an increase of 30.07% from the current stock price of 10.51.
Analyst Consensus: Buy
* Price targets were last updated on May 18, 2026.
Analyst Ratings
The average analyst rating for Atara Biotherapeutics stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 2 | 2 | 2 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 1 | 1 | 1 | 0 |
| Total | 5 | 5 | 5 | 5 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Freedom Capital Markets | Freedom Capital Markets | Hold Upgrades $4 → $10 | Hold | Upgrades | $4 → $10 | -4.85% | May 18, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $13 | Buy | Maintains | $13 | +23.69% | May 13, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $18 | Buy | Maintains | $18 | +71.27% | Mar 30, 2026 |
Financial Forecast
Revenue This Year
2.11M
from 120.77M
Decreased by -98.26%
Revenue Next Year
45.08M
from 2.11M
Increased by 2,040.99%
EPS This Year
-0.88
from 2.57
EPS Next Year
1.27
from -0.88
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.0M | 60.0M | |
| Avg | 2.1M | 45.1M | |
| Low | 516,000 | 31.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -95.9% | 2,749.9% | |
| Avg | -98.3% | 2,041.0% | |
| Low | -99.6% | 1,372.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.53 | 2.60 | |
| Avg | -0.88 | 1.27 | |
| Low | -1.23 | 0.20 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.